Isolation and Characterization of Extracellular Vesicles Produced by Iron-limited Mycobacteria
October 31st, 2019
6.9K views
Mycobacterium tuberculosis shows increased production and release of extracellular vesicles in response to low iron conditions. This work details a protocol for generating low iron conditions and methods for the purification and characterization of mycobacterial extracellular vesicles released in response to iron deficiency.
Overview
This study presents a protocol for culturing Mycobacterium tuberculosis under low iron conditions, which enhances the production of extracellular vesicles. The methods for purification and characterization of these vesicles are detailed, providing insights into their potential biochemical applications.
Key Study Components
Area of Science
- Microbiology
- Cell Biology
- Biochemistry
Background
- Mycobacterium tuberculosis is known to respond to iron limitation.
- Extracellular vesicles play a role in bacterial communication and pathogenesis.
- Understanding vesicle production can aid in developing therapeutic strategies.
- Low iron conditions stimulate the production of membrane vesicles.
Purpose of Study
- To establish a reliable method for culturing M. tuberculosis under low iron conditions.
- To purify and characterize the extracellular vesicles produced in response to iron deficiency.
- To provide a protocol that can be utilized in BSL-2 facilities.
Methods Used
- Preparation of minimal medium with specific components.
- Adjustment of pH and addition of metal chelating resin.
- Culturing of M. tuberculosis under controlled low iron conditions.
- Purification of membrane vesicles from culture filtrate.
Main Results
- High abundance of pure membrane vesicles was obtained.
- The protocol was demonstrated using Mycobacterium smegmatis.
- Results indicate that iron limitation effectively stimulates vesicle production.
- Purified vesicles can be used for further biochemical assays.
Conclusions
- The established protocol is effective for studying extracellular vesicles in M. tuberculosis.
- Understanding vesicle production can enhance knowledge of bacterial pathogenesis.
- This method can facilitate future research on mycobacterial biology.
Frequently Asked Questions
What are extracellular vesicles?
Extracellular vesicles are membrane-bound particles released by cells that can carry proteins, lipids, and nucleic acids.
Why is iron limitation important for Mycobacterium tuberculosis?
Iron limitation stimulates the production of extracellular vesicles, which may play a role in the bacterium's survival and pathogenicity.
Can this protocol be used in other bacterial species?
While this protocol is designed for Mycobacterium tuberculosis, it may be adapted for other species that respond to iron limitation.
What safety precautions are necessary when working with Mycobacterium tuberculosis?
Work with Mycobacterium tuberculosis should be conducted in BSL-2 facilities with appropriate safety measures in place.
What applications can purified vesicles be used for?
Purified vesicles can be used for biochemical assays, studies on bacterial communication, and potential therapeutic developments.
How does the purification process work?
The purification process involves filtering the culture filtrate to isolate the membrane vesicles, which can then be characterized biochemically.
Executive Industry Relevance
This protocol enables the isolation of extracellular vesicles from iron-limited mycobacteria, providing a scalable source of pathogen-derived biomolecules for target validation and assay development. By enhancing vesicle yield under host-relevant conditions, it supports mechanistic de-risking of tuberculosis therapeutic candidates through defined pathogen-host interface components. The method delivers standardized, quantifiable vesicle preparations suitable for downstream screening and biomarker discovery workflows.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of pathogen-derived molecular cargo for target hypothesis testing.
- Operational Value: Provides purified vesicles from iron-limited cultures to validate target engagement in disease-relevant conditions.
Screening & Assay Development
- Scientific Value: Delivers standardized vesicle preparations for developing immunoassays or functional readouts.
- Operational Value: Supports assay reproducibility through consistent vesicle yield and size distribution under controlled iron restriction.
Translational & Preclinical Research
- Scientific Value: Facilitates study of vesicle-host interactions relevant to pathogenesis and immune modulation.
- Operational Value: Enables longitudinal tracking of vesicle biomarkers across infection models.
Pipeline & Workflow Integration
The method fits within early discovery workflows by supplying pathogen-derived extracellular vesicles for target validation and assay optimization prior to lead identification.
- Discovery Biology: Supports hypothesis testing on vesicle-associated virulence factors and immunomodulatory molecules.
- Screening: Enables preparation of standardized vesicle inputs for high-throughput binding or functional assays.
- Analytics: Provides quantifiable outputs including vesicle size (~100 nm), protein/lipid concentration, and density gradient fractionation data.
- Translational Research: Connects vesicle composition to disease-relevant iron-limited conditions mimicking the host environment.
- Enterprise Reuse: Establishes a scalable platform for producing mycobacterial vesicles across multiple projects and strains.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by using vesicles produced under physiologically relevant iron stress.
- Operational Value: Delivers eight-fold higher vesicle yield under low iron versus high iron conditions, improving material efficiency.
- Strategic Value: Reduces biological de-risking timelines by providing standardized pathogen-derived inputs for early assay development.
- Portfolio Impact: Enables data-driven go/no-go decisions based on vesicle-associated target engagement in iron-limited models.
Implementation Considerations
- Requires expertise in mycobacterial culture handling and BSL-2 containment for virulent strains.
- Depends on access to ultrafiltration, ultracentrifugation, and iodixanol gradient preparation equipment.
- Necessitates standardization of iron chelation and metal supplementation across production batches.
- Involves adaptation considerations when extending the protocol to other bacterial species or growth conditions.
- Includes practical limitations such as the 14-day incubation period and multi-step purification timeline.
Biopharma FAQs
Why does iron limitation matter for extracellular vesicle yield in mycobacteria?
Iron limitation stimulates membrane vesicle production, resulting in approximately eight-fold higher yield compared to iron-sufficient conditions, as shown by protein and lipid concentration normalized to colony forming units.
How does density gradient fractionation enable vesicle purification in this protocol?
Iodixanol density gradient centrifugation separates membrane vesicles primarily into fraction three (25% iodixanol), where vesicle-associated proteins and lipids are concentrated, as confirmed by dot blot and nanoparticle analysis.
What quantitative measurements validate extracellular vesicle purity and size?
Nanoparticle analysis shows a mean vesicle size of approximately 100 nanometers, while dot blot analysis confirms enrichment of vesicle-associated markers in the purified gradient fraction.
Why are replication requirements important for vesicle production across experimental batches?
Consistent vesicle yield and size depend on strict adherence to iron-limited culture conditions, including metal chelation duration and supplementation controls, to ensure reproducibility across runs.
What analytical capabilities are required before implementing this vesicle purification workflow?
Implementation requires access to spectrophotometry for OD measurement, ultracentrifugation for pelleting, fluorescence spectrometry for lipid probe assays, and equipment for iodixanol gradient preparation and fractionation.
Chapters in this video
0:04
Title
0:47
Preparation of Iron-depleted Defined Medium
1:58
Growing Mycobacteria in Iron-limited Conditions
3:44
Collection, Isolation and Quantification of MEVs (Mycobacterial Extracellular Vesicles)
6:38
Results: MEV Purification and Quantification
7:49
Conclusion
